MedTrace Logo

Gastrointestinal Symptoms in Healthy Subjects and Patients With Irritable Bowel Syndrome

NCT01457378 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2016-09-20

No results posted yet for this study

Summary

The aim of this study performed in Irritable Bowel Syndrome (IBS) subjects and healthy patients is to demonstrate the ability of composite score of frequency of gastrointestinal symptoms to discriminate healthy subjects and IBS patients. The properties of this questionnaire of composite score of gastrointestinal symptoms frequency will be compared to other validated questionnaires (severity of IBS symptoms and HRQoL).

Conditions

  • Irritable Bowel Syndrome

Sponsors & Collaborators

  • Danone Global Research & Innovation Center

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2011-10-31
Completion
2011-11-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01457378 on ClinicalTrials.gov